Targeting the B7/CD28:CTLA-4 costimulatory system in CNS autoimmune disease

Journal of Neuroimmunology

Volumn 89, Issue 1-2, 1998, Pages 10-18

  Karandikar, Nitin J ^a   Vanderlugt, Carol L ^a   Bluestone, Jeffrey A ^b   Miller, Stephen D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

B7 CD28:CTLA 4 costimulatory system; Central nervous system (CNS); Experimental autoimmune encephalomyelitis (EAE)

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MONOCLONAL ANTIBODY;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; DEMYELINATING DISEASE; IMMUNIZATION; IMMUNOSTIMULATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RELAPSE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS;

EID: 0032516753     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00058-7     Document Type: Article

References (63)

1. Borriello F., Freeman G.J., Edelhoff S., Disteche C.M., Nadler L.M., Sharpe A.H. Characterization of the murine B7-1 genomic locus reveals an additional exon encoding an alternative cytoplasmic domain and a chromosomal location of chromosome 16, band B5. J. Immunol. 153:1994;5038-5048.
2. Borriello F., Oliveros J., Freeman G.J., Nadler L.M., Sharpe A.H. Differential expression of alternate mB7-2 transcripts. J. Immunol. 155:1995;5490-5497.
3. Borriello F., Sethna M.P., Boyd S.D., Schweitzer A.N., Tivol E.A., Jacoby D., Strom T.B., Simpson E.M., Freeman G.J., Sharpe A.H. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity. 6:1997;303-313.
4. Brunet J.F., Denizot F., Luciani M.F., Roux-Dosseto M., Suzan M., Mattei M.G., Golstein P. A new member of the immunoglobulin superfamily - CTLA-4. Nature. 328:1987;267-270.
5. Chambers C.A., Krummel M.F., Boitel B., Hurwitz A., Sullivan T.J., Fournier S., Cassell D., Brunner M., Allison J.P. The role of CTLA-4 in the regulation and initiation of T cell responses. Immunol. Rev. 153:1996;27-46.
6. Damle N.K., Klussman K., Leytze G., Myrdal S., Aruffo A., Ledbetter J.A., Linsley P.S. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7. J. Immunol. 152:1994;2686-2697.
7. Dariavach P., Mattei M.G., Golstein P., Lefranc M.P. Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur. J. Immunol. 18:1988;1901-1905.
8. Finck B.K., Linsley P.S., Wofsy D. Treatment of murine lupus with CTLA4Ig. Science. 265:1994;1225-1227.
9. Freeman G.J., Boussiotis V.A., Anumanthan A., Bernstein G., Ke X., Rennert P.D., Gray G.S., Gribben J.G., Nadler L.M. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity. 2:1995;523-532.
10. Gonatas N.K., Greene M.I., Waksman B.H. Genetic and molecular aspects of demyelination. Immunol. Today. 7:1986;121-126.
11. Gribben J.G., Freeman G.J., Boussiotis V.A., Rennert P., Jellis C.L., Greenfield E., Barber M., Resvito V.A., Ke X., Gray G.S., Nadler L.M. CTLA4 mediates antigen-specific apoptosis of human T cells. Proc. Natl. Acad. Sci. USA. 92:1995;811-815.
12. Harrison N., Peach R., Naemura J., Linsley P.S., Le Gros G., Ronchese F. CD80 costimulation is essential for the induction of airway eosinophilia. J. Exp. Med. 185:1997;177-182.
13. Hathcock K.S., Laszlo G., Dickler H.B., Bradshaw J., Linsley P., Hodes R.J. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science. 262:1993;905-907.
14. Hurwitz A.A., Sullivan T.J., Krummel M.F., Sobel R.A., Allison J.P. Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively- induced model of experimental allergic encephalomyelitis. J. Neuroimmunol. 73:1997;57-62.
15. Inobe M., Linsley P.S., Ledbetter J.A., Nagai Y., Tamakoshi M., Uede T. Identification of an alternatively spliced form of the murine homologue of B7. Biochem. Biphys. Res. Commun. 1:1994;443-449.
16. Inobe M., Aoki N., Linsley P.S., Ledbetter J.A., Abe R., Murakami M., Uede T. The role of the B7-1a molecule, an alternatively spliced form of murine B7-1 (CD80), on T cell activation. J. Immunol. 157:1996;582-588.
17. June C.H., Bluestone J.A., Nadler L.M., Thompson C.B. The B7 and CD28 receptor families. Immunol. Today. 15:1994;321-331.
18. Karandikar N.J., Vanderlugt C.L., Walunas T.L., Miller S.D., Bluestone J.A. CTLA-4: a negative regulator of autoimmune disease. J. Exp. Med. 184:1996;783-788.
19. Karandikar et al., submitted.
20. + T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155:1995;1032-1036.
21. Kennedy K.J., Smith W.S., Miller S.D., Karpus W.J. Induction of antigen-specific tolerance for the treatment of ongoing, relapsing autoimmune encephalomyelitis - a comparison between oral and peripheral tolerance. J. Immunol. 159:1997;1036-1044.
22. Krummel M.F., Allison J.P. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:1995;459-465.
23. Kuchroo V.K., Das M.P., Brown J.A., Ranger A.M., Zamvil S.S., Sobel R.A., Weiner H.L., Nabavi N., Glimcher L.H. B7-1 and B7-2 costimulatory molecules differentially activate the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 80:1995;707-718.
24. Lanier L.L., O'Fallon S., Somoza C., Phillips J.H., Linsley P.S., Okumura K., Ito D., Azuma M. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J. Immunol. 154:1995;97-105.
25. Leach D.R., Krummel M.F., Allison J.P. Enhancement of antitumor immunity by CTLA-4 blockade. Science. 271:1996;1734-1736.
26. Lehmann P.V., Forsthuber T., Miller A., Sercarz E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature. 358:1992;155-157.
27. Lenschow D.J., Zeng Y., Thistlethwaite J.R., Montag A., Brady W., Gibson M.G., Linsley P.S., Bluestone J.A. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science. 257:1992;789-792.
28. Lenschow D.J., Su G.H., Zuckerman L.A., Nabavi N., Jellis C.L., Gray G.S., Miller J., Bluestone J.A. Expression and functional significance of an additional ligand for CTLA-4. Proc. Natl. Acad. Sci. USA. 90:1993;11054-11058.
29. Lenschow D.J., Sperling A.I., Cooke M.P., Freeman G., Rhee L., Decker D.C., Gray G., Nadler L.M., Goodnow C.C., Bluestone J.A. Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. J. Immunol. 153:1994;1990-1997.
30. Lenschow D.J., Ho S.C., Sattar H., Rhee L., Gray G., Nabavi N., Herold K.C., Bluestone J.A. Differential effects of anti-B7-1 and anti-B7-2 mAb treatment on the development of diabetes in the NOD mouse. J. Exp. Med. 181:1995;1145-1155.
31. Lenschow D.J., Zeng Y., Hathcock K.S., Zuckerman L.A., Freeman G., Thistlethwaite J.R., Gray G.S., Hodes R.J., Bluestone J.A. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibody. Transplantation. 60:1995;1171-1178.
32. Lenschow D.J., Walunas T.L., Bluestone J.A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:1996;233-258.
33. + T cells and induce similar patterns of cytokine secretion in vitro. Int. Immunol. 7:1995;891-904.
34. Lin H., Bolling S.F., Linsley P.S., Wei R.Q., Gordon D., Thompson C.B., Turka L.A. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J. Exp. Med. 178:1993;1801-1806.
35. Linsley P.S., Clark E.A., Ledbetter J.A. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc. Natl. Acad. Sci. USA. 87:1990;5031-5035.
36. Linsley P.S., Brady W., Grosmaire L., Aruffo A., Damle N.K., Ledbetter J.A. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:1991;721-730.
37. Linsley P.S., Brady W., Urnes M., Grosmaire L.S., Damle N.K., Ledbetter J.A. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:1991;561-569.
38. Linsley P.S., Greene J.L., Tan P., Bradshaw J., Ledbetter J.A., Anasetti C., Damle N.K. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176:1992;1595-1604.
39. Linsley P.S., Wallace P.M., Johnson J., Gibson M.G., Greene J.L., Ledbetter J.A., Singh C., Tepper M.A. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science. 257:1992;792-795.
40. Linsley P.S., Green J.L., Brady W., Bajorath J., Ledbetter J.A., Peach R. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity. 1:1994;793-801.
41. Linsley P.S., Bradshaw J., Green J., Peach R., Bennett K.L., Mittler R.S. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity. 4:1996;535-543.
42. Marengere L.E.M., Waterhouse P.W., Duncan G.S., Mittrucker H.W., Feng G.S., Mak T.W. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science. 272:1996;1170-1173.
43. McRae B.L., Kennedy M.K., Tan L.J., Dal Canto M.C., Miller S.D. Induction of active and adoptive chronic-relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J. Neuroimmunol. 38:1992;229-240.
44. McRae B.L., Vanderlugt C.L., Dal Canto M.C., Miller S.D. Functional evidence for epitope spreading in the relapsing pathology of EAE in the SJL/J mouse. J. Exp. Med. 182:1995;75-85.
45. Miller S.D., Tan L.J., Pope L., McRae B.L., Karpus W.J. Antigen-specific tolerance as a therapy for experimental autoimmune encephalomyelitis. Int. Rev. Immunol. 9:1992;203-222.
46. Miller S.D., Vanderlugt C.L., Lenschow D.J., Pope J.G., Karandikar N.J., Dal Canto M.C., Bluestone J.A. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity. 3:1995;739-745.
47. Murphy M.L., Engwerda C.R., Gorak P.M., Kaye P.M. B7-2 blockade enhances T cell responses to Leishmania donovani. J. Immunol. 159:1998;4460-4466.
48. Peach R.J., Bajorath J., Brady W., Leytze G., Greene J., Naemura J., Linsley P.S. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1. J. Exp. Med. 180:1994;2049-2058.
49. Perez V.L., Parijs L.V., Biuckians A., Zheng X.X., Strom T.B., Abbas A.K. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity. 6:1997;411-417.
50. Perrin P.J., Scott D., Quigley L., Albert P.S., Feder O., Gray G.S., Abe R., June C.H., Racke M.K. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. J. Immunol. 154:1995;1481-1490.
51. Perrin P.J., Maldonado J.H., Davis T.A., June C.H., Racke M.K. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J. Immunol. 157:1996;1333-1336.
52. Subramanian G., Kazura J.W., Pearlman E., Jia X., Malhotra I., King C.L. B7-2 requirement for helminth-induced granuloma formation and CD4 type 2 T helper cell cytokine expression. J. Immunol. 158:1997;5914-5920.
53. Tan L.-J., Kennedy M.K., Dal Canto M.C., Miller S.D. Successful treatment of paralytic relapses in adoptive experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance. J. Immunol. 147:1991;1797-1802.
54. Tivol E.A., Borriello F., Schweitzer A.N., Lynch W.P., Bluestone J.A., Sharpe A.H. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical immunoregulatory role of CTLA-4. Immunity. 3:1995;541-547.
55. Tsuyuki S., Tsuyuki J., Einsle K., Kopf M., Coyle A.J. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J. Exp. Med. 185:1997;1671-1679.
56. Tuohy V.K., Lu Z., Sobel R.A., Laursen R.A., Lees M.B. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142:1989;1523-1527.
57. Vanderlugt C.L., Karandikar N.J., Lenschow D.J., Dal Canto M.C., Bluestone J.A., Miller S.D. Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAE. J. Neuroimmunol. 79:1997;113-118.
58. Walunas T.L., Lenschow D.J., Bakker C.Y., Linsley P.S., Freeman G.J., Green J.M., Thompson C.B., Bluestone J.A. CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1:1994;405-413.
59. Walunas T.L., Bakker C.Y., Bluestone J.A. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183:1996;2541-2550.
60. Waterhouse P.W., Penninger J.M., Timms E., Wakeham A., Shahinian A., Lee K.P., Thompson C.B., Griesser H., Mak T.W. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science. 270:1995;985-988.
61. Wekerle H. Immunopathogenesis of multiple sclerosis. Acta Neurol. 13:1991;197-204.
62. Wu Y., Guo Y., Huang A., Zheng P., Liu Y. CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion. J. Exp. Med. 185:1997;1327-1335.
63. + Th2 cells for contact hypersensitivity. J. Immunol. 159:1998;4217-4226.